Form Type: 4

SEC EDGAR Link
Accession Number:0001808805-21-000026
Date:2021-11-30
Issuer: NAUTILUS BIOTECHNOLOGY, INC. (NAUT)
Original Submission Date:

Reporting Person:

POSARD MATTHEW L.
C/O NAUTILUS BIOTECHNOLOGY, INC.
2701 EASTLAKE AVENUE EAST SEATTLE, WA 98102

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-11-30 P 20,000 a $4.57 20,000 direct
COMMON STOCK 2021-12-01 P 10,000 a $4.50 30,000 direct
COMMON STOCK 2021-12-01 P 10,000 a $4.46 40,000 direct
COMMON STOCK 2021-12-01 P 10,000 a $4.45 50,000 direct
COMMON STOCK 2021-11-30 0 $0.00 100,000 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 shares held by the matthew and elizabeth posard trust. the reporting person is the trustee of the matthew and elizabeth posard trust.
WhaleWisdom Logo

Elevate your investments